Sr. No | Product Name | Strength | Region | Format | Module | BE Study |
---|---|---|---|---|---|---|
751 | CEFUROXIME SODIUM | Powder solution for Inj 500 mg/1000 mg IM IV,Powder solution for Inj 1000 mg IM | CTD | Reference Data | ||
752 | CEFTRIAXONE SODIUM | 250 mg/500 mg/1000 mg/2000 mg /vial inj | CTD | Reference Data | ||
753 | TIGECYCLINE | 50 mg Lyophilized powder for solution | CTD | Reference Data | ||
754 | ACEMETACINE | 60 mg Forte Capsule | CTD | Reference Data | ||
755 | CARBOPLATIN | 50 mg/150 mg/450 mg/600 mg V IV infusion | CTD | Reference Data | ||
756 | OLOPATADIN | % 0,2 eye drop,% 0,7 eye drop | CTD | Reference Data | ||
757 | OXALIPLATIN | 50 mg/100 mg/ 200 mg infusion solution | CTD | Reference Data | ||
758 | VITAMIN D3 | 600 IU/1000 IU/5000 IU/50000 IU capsule, 400 IU / 5 ml drop oral liquid | CTD | Reference Data | ||
759 | VITAMIN D3 + Vitamin K2 | 10000 IU & 50 mcg soft gel capsule | CTD | Reference Data | ||
760 | CO ENZYME QH | 100 mg capsule | CTD | Reference Data | ||
761 | BIVALIRUDIN | 250 mg/vial Lyop. Powder for inj. | CTD | Reference Data | ||
762 | OXITROPIUM | 100 mcg MDI | CTD | Reference Data | ||
763 | DOXORUBICINE | ready to use inj | CTD | Reference Data | ||
764 | EPIRUBICIN | ready to use inj | CTD | Reference Data | ||
765 | FLUOROURACIL | 1000 mg 20 ml sol for inj or inf.,50 mg 100 ml sol for inj or inf. | CTD | Reference Data | ||
766 | QUETIAPINE | 50 MG SR FILM TABLET | CTD | Reference Data | ||
767 | LEVADOPA + BENSERAZIDE HCL | 125 mg tablet, 250 mg tablet,125 mg kapsül | CTD | Reference Data | ||
768 | CLONAZEPAM | 2 mg tablet, 2,5 mg / ml damla | CTD | Reference Data | ||
769 | DEXMEDETAMIDINE | 400 mcg / 4 ml, 200 mcg / 2 ml, 100 mcg / 10 ml | CTD | Reference Data | ||
770 | SUGAMMADEX | 500 mg / 5 ml, 200 mg / 2 mlMeloxicam 20mg/ml | CTD | Reference Data | ||
771 | Meloxicam 20mg/ml | 50 ml ve 100 ml | CTD | Reference Data | ||
772 | Florfenicol 300 mg/ml | 50ml; 100 ml; 200ml | CTD | Reference Data | ||
773 | Ivermectin 5 mg/ml | 500ml;1000 ml | CTD | Reference Data | ||
774 | Levamisole HCL (3,75%w/v)+ Triclabendazole(5%w/v) | 500ml;1000 ml | CTD | Reference Data | ||
775 | Levamisole HCL (3,75%w/v)+ Triclabendazole(5%w/v) | 500ml;1000 ml | CTD | Reference Data | ||
776 | CARVEDILOL | Karvedilol 6.25 mg/tb, Karvedilol 12.5 mg/tb, Karvedilol 25 mg/tb | CTD | Reference Data | ||
777 | ABIRATERONE | 250 mg tablet | CTD | Reference Data | ||
778 | CILAZAPRIL | 1 mg, 2.5 mg, 5 mg | CTD | Reference Data | ||
779 | CILAZAPRIL+HCTZ | 5 mg + 12,5 mg | CTD | Reference Data | ||
780 | DEXPANTHENOL+SODIUM HYALURONATE | Dexpanthenol 2% + Sodium Hyaluronate 0,15% in 20×0,5 ml BFS (single dose)(multi dose) | CTD | Reference Data | ||
781 | SPIRAMYCIN 600.000 IU/ml | 50ml; 100 ml; 250ml | CTD | Reference Data | ||
782 | RIFAXIMIN IMM | 5 ml syringe //100mg/syringe | CTD | Reference Data | ||
783 | LEVAMISOLE HCL 40mg/ml +ABAMECTIN 1 mg/ml | 250 ml; 1000 ml; 2500 ml | CTD | Reference Data | ||
784 | LEVAMISOLE HCL 40mg/ml +ABAMECTIN 1 mg/ml | 250 ml; 1000 ml; 2500 ml | CTD | Reference Data | ||
785 | LEVAMISOLE HCL 40mg/ml +ABAMECTIN 1 mg/ml +ALBENDAZOLE 25 mg/ml | 250 ml; 1000 ml; 2500 ml | CTD | Reference Data | ||
786 | LEVAMISOLE HCL 37,5 mg/ml +ALBENDAZOLE 23,8 mg/ml -sheep | 250 ml; 1000 ml; 2500 ml | CTD | Reference Data | ||
787 | LEVAMISOLE HCL 75 mg/ml +ALBENDAZOLE 100 mg/ml -cattle | 250 ml; 1000 ml; 2500 ml | CTD | Reference Data | ||
788 | PREDNISOLONE | %1 / 5ml multidose eye drop | CTD | Reference Data | ||
789 | ATOMEXETIN | 10 mg/18 mg/25 mg/40 mg/60 mg/80 mg/100 mg capsule | CTD | Reference Data | ||
790 | ILOPROST | 20 MCG/ML | CTD | Reference Data | ||
791 | CYCLOSPORIN | %0,1 Oftalmik emülsiyon (ikervis muadili) | CTD | Reference Data | ||
792 | SUNITINIB | 12.5 MG,25 MG,37.5 MG,50 MG | CTD | Reference Data | ||
793 | AZITROMYCINE | %1,5 OPHTALMIC SOLUTION BFS | CTD | Reference Data | ||
794 | DEFERASIROX | 125 MG/250 MG/500 MG DISPERSIBLE TABLET | CTD | Reference Data | ||
795 | GLYCOPYRONIUM | 50 MCG 30 INH CAPS/50 MCG 90 INH CAPS | CTD | Reference Data | ||
796 | FLUTICASONE & FORMATEROL | 125 MCG + 5 MCG 120 DASE, 250 MCG + 10 MCG 120 DOSE, 50 MCG + 5 MCG 120 DOSE MDI |
CTD | Reference Data | ||
797 | DEXAMETHASONE | 0,1 % OPHTALMIC OINTMENT | CTD | Reference Data | ||
798 | BROMFENAC | 0,07 % MULTI & SINGLE DOSE OPHTALMIC SOLUTION BFS | CTD | Reference Data | ||
799 | PRASUGREL + ASA | 10 MC + 75 MG FİLM TABLET | CTD | Reference Data | ||
800 | BRIMONIDIN | 0,1 % MULTI DOSE,0,1 % MULTI DOSE% 0,15 multi dose (Tuğçe Cengiz 05.04.16 maili ile eklendi),td> | CTD | Reference Data | ||
801 | FORMOTEROL FUMARATE/td> | 20 MCG/2 ML | CTD | Reference Data | ||
802 | NICARDIPINE | 0,2 MG/ML/0,1 MG/ML ACL),0,1 MG/ML/0.2 MG/ML DEXTROSE)/td> | CTD | Reference Data | ||
803 | BECLOMETHASONE | 100 MCG NASAL SPREY | CTD | Reference Data | ||
804 | SODIUM HYALURONATE | 0,15 % multi dose eye drop, 0,15 % unit dose eye drop | CTD | Reference Data | ||
805 | BRIMONIDIN + BRINZOLOMIDE | %1 + %0,2 5 ML OPHTALMIC SUSPENSION | CTD | Reference Data | ||
809 | OXITROPIUM BUDESONID FORMETEROL | 100 MCG+160 MCG+4,5 MCG 120 DOSES,100 MCG+80 MCG+4,5 MCG 120 DOSES | CTD | Reference Data | ||
810 | CALCITRIOL | 0,25 MCG,0,5 MCG/td> | CTD | Reference Data | ||
811 | MEGESTROL ACETATE | 160 MG | CTD | Reference Data | ||
812 | DASATINIB | 20 MG/50 MG/70 MG | CTD | Reference Data | ||
813 | NYSTATIN | 100.000 IU SUSPENSION | CTD | Reference Data | ||
814 | HYDROXY UREA | 500 MG | CTD | Reference Data | ||
815 | TRIAMCINOLON ACETONID | %0,1 ORABASE OINTMENT | CTD | Reference Data | ||
816 | TENOXICAM | 20 MG/3ML 1 FLAKON+2 ML SOLVENT | CTD | Reference Data | ||
817 | PANTOPRAZOLE | 40 MG 10&25 DRY VIAL | CTD | Reference Data | ||
818 | CATIONORM OPHTALMIC SOLUTION | ophtalmic solution %0,1 | CTD | Reference Data | ||
819 | VITAMIN D3 | 10.000 IU&20.000 IU soft gel capsule | CTD | Reference Data | ||
820 | AMOXICILLIN TRIHIDRAD+POTASSIUM CLAVULANATE | 1000 MG+200 MG IV | CTD | Reference Data | ||
821 | SODIUM HYALURONATE | 25 MG /50 MG /100 MGSOFT GEL CAPSULE | CTD | Reference Data | ||
822 | TIOTROPIUM BROMIDE | 18 MCG DOSE DRY POWDER INHALER | CTD | Reference Data | ||
823 | OXITROPIUM BR + FORMOTEROL FUMARATE | 100 MCG + 6 MCG 120 DOSES,200 MCG + 12 MCG 60 DOSES/td> | CTD | Reference Data | ||
824 | DEXAMETHASONE + NETILMISIN | MULTIDOSE 5 ML EYE DROPS | CTD | Reference Data | ||
825 | TEICOPLANINE | 200MG/400 MG | CTD | Reference Data | ||
826 | FLUDROKORTIZON | 0,1 MG TABLET | CTD | Reference Data | ||
827 | FLORFENICOL 450MG/ML | 50 ML,100 M,200 ML | CTD | Reference Data | ||
828 | FENBENDAZOLE+LEVAMISOLE HCL | 250 ML, 1000 ML, 2500 ML | CTD | Reference Data | ||
829 | POMALIDOMIDE | 1 MG/2 MG/3 MG/4 MG CAPSULE | CTD | Reference Data | ||
830 | ARFORMOTEROL TARTRATE | 15 MCG/2 ML 30 NEBULE/PACK,15 MCG/2 ML 60 NEBULE/PACK | CTD | Reference Data | ||
831 | ANIDULAFUNGIN | 100 MG 1 VIAL,50 MG 1 VIAL ONLY FOR MA | CTD | Reference Data | ||
832 | FLUOROMETHOLONE ACETATE | % 0,1 5ML/BOTTLE/BOX | CTD | Reference Data | ||
833 | B-C VİTAMİN KOMPLEKS ENJEKSİYONLUK ÇÖZELTİ | 50 ML, 100 MLDIMETHYL FUMARATE | CTD | Reference Data | ||
834 | DIMETHYL FUMARATE | 120 MG/240 MG CAPSULE | CTD | Reference Data | ||
835 | INDACATEROL DPI | 150/300 MCG | CTD | Reference Data | ||
836 | FULVESTRANT | 250 MG/5 ML SOLUTION FOR INJECTION | CTD | Reference Data | ||
837 | PHENYRAMIDOL | 400 MG TABLET | CTD | Reference Data | ||
838 | PHENYRAMIDOL | 400 MG TABLET,800 MG/3 ML AMPUL | CTD | Reference Data | ||
839 | AMITRIPTYLINE HYDROCHLORIDE | 10 mg/25 mg/50 mg tablet | CTD | Reference Data | ||
840 | ETODOLAK-GE-1 | 600 SR TABLET, 500 mg Film tablet | CTD | Reference Data | ||
841 | SEFUROKSİM SODYUM-GE-2 | 250 MG/500 MG/750 MG EFERVECENT TABLET,CEFAKS 1.5 GRAM/ML IV | CTD | Reference Data | ||
842 | NIMESULID-GE-3 | 100 MG EFERVECENT TABLETACETYL CYSTEIN-GE-4 | CTD | Reference Data | ||
843 | ACETYL CYSTEIN-GE-4 | 1200 mg/900 mg/600 mg EFERVECENT TABLET | CTD | Reference Data | ||
844 | CARVEDILOL PHOSPHATE-GE-5 | 80 MG CR CAPSULE | CTD | Reference Data | ||
845 | AMOKSİSLİN+KLAVULANIK ASİT-GE-6 | 1000 MG SR TABLET,AMOKLAVIN BID 400MG/57MG SACHET,200MG/28.5MG Sachet | CTD | Reference Data | ||
846 | CEFUROXIME AXETIL-GE-7 | CEFAKS 125 MG SACHET,CEFAKS 250 MG SACHET | CTD | Reference Data | ||
847 | Etofnamt+Bnzl Nic.+BenAlko-GE-8 | 100 MG/10 MG/ 15 MG CREAM,1 G/2 ML AMPULE (Sadece Etofenemat), % 5 GEL,40 g (Sadece Etofenemat) | CTD | Reference Data | ||
848 | SULPHMETHXAZOL+TRIMETHOPR-GE-9 | CTD | Reference Data | |||
849 | BENIDIPINE HCI-GE-10 | 8 MG TABLET | CTD | Reference Data | ||
850 | QUETIAPIN-GE-11 | 50 MG/200 MG, 300 MG, 400 MG XR TABLET | CTD | Reference Data | ||
851 | CYANOCOBALAMIN-GE-12 | 1000 MG IV | CTD | Reference Data | ||
852 | CHLORAMPHENICOL-GE-13 | 1 G LYOPILIZED INJECTABLE FLACON,1 % 0.01 G POMAD,5 MG TABLET,50 MG TRIAMTEREM + 25 MG HCTZ CAPSULE | CTD | Reference Data | ||
853 | MERACOL-GE-16 | CTD | Reference Data | |||
854 | DESLORATADINE-GE-17 | 5 MG ODT | CTD | Reference Data | ||
855 | B1 + B6 + B12 | 50 MG INJECTABLE | CTD | Reference Data | ||
856 | TOLDIMFOS | 50 MG /ML INJACTABLE LIQUID | CTD | Reference Data | ||
857 | VITAMIN B12 + VITAMIN C | 2.5 MG VITAMIN B12 + 150 MG VITAMIN C INJECTABLE AMPOULE | CTD | Reference Data | ||
858 | FLUNIXIN | 50 MG /ML INJACTABLE LIQUID | CTD | Reference Data | ||
859 | QUETIAPINE FUMARATE | 400 mg/tablet Immediate Release | CTD | Reference Data | ||
860 | Oxiconazole Nitrate Micronize | OCERAL %1 KREM, 10 GR,OCERAL 10mg/mL SPREY, 20 mL | CTD | Reference Data | ||
861 | Marbofloxacine (API) | CTD | Reference Data | |||
862 | Cetirizin HCl (10 mg Cetirizin HCl/tb) | CTD | Reference Data | |||
863 | Hydrochlorotiazide (5 mg Silazapril + 12,5 mg Hydrochlorotiazide/tb) | CTD | Reference Data | |||
864 | Bicalutamide EU (50 mg/tb) | CTD | Reference Data | |||
865 | Amoksisilin Trihidrat (Purimox Powder Grade E) Oral Süspansiyon | CTD | Reference Data | |||
866 | Dekspantenol/Panthenol % 5 Krem/API: Parkim | CTD | Reference Data | |||
867 | Hydroxyurea/Hydrea 500 mg Kapsül/ API: Euticals | CTD | Reference Data | |||
868 | Amoksisilin Trihidrat DC/ Amoklavin 1000 mg Film Tablet/ API: The United & Sinopharm | CTD | Reference Data | |||
869 | Sildenafil Sitrat/Degra 100 mg Film Tablet /API: Hetero | CTD | Reference Data | |||
870 | Karvedilol / Delotran 3.125 mg Tablet / API: Polpharma | CTD | Reference Data | |||
871 | Parasetamol / Pirofen Şurup | 60 MG,120 MG,180 MG FILM TABLET | CTD | Reference Data | ||
872 | MİRTAZAPİN PROJESİ-T-2 | 15 MG ,30 MG ,45 MG ODT | CTD | Reference Data | ||
873 | IRINOTECAN HCI PROJESİ-T-3 | 40 MG /2 ML INFUSION (FLACON), 100 MG /5 ML INFUSION (FLACON) |
CTD | Reference Data | ||
874 | ZOLEDRONIC PROJESİ-T-4 | 4 MG/5 ML IV INFUSION (FLACON) | CTD | Reference Data | ||
875 | LEVODOPA+CARBIDOPA+ENTA PRJ-T-5 | 40 MG IV LIOPHILIZED FLACON | CTD | Reference Data | ||
876 | PANTOPRAZOL | 50/12.5/200 MG FILM TABLET,100/25/200 MG FILM TABLET,150/37.5/200 MG FILM TABLET,200/50/200 MG FILM TABLET | CTD | Reference Data | ||
877 | GRANISETRON HCI-T-6 | 3MG / 3 ML AMPOULE | CTD | Reference Data | ||
878 | LEUPROLIDE ACETATE-T-9 | 1 MG/0.2 ML IV VIAL (FLACON) | CTD | Reference Data | ||
879 | METHOTREXATE-T-10 | CTD | Reference Data | |||
880 | 5-FLUOROURACIL-T-11 | 1000 MG/20 ml IV VIAL (FLACON) | CTD | Reference Data | ||
881 | ETOPOSIDE-T-12 | 100 MG/5 ml IV VIAL (FLACON), 200 MG/10 ml IV VIAL (FLACON), 500 MG/25 ml IV VIAL (FLACON), 1000 MG/50 ml IV VIAL (FLACON) |
CTD | Reference Data | ||
882 | VINCRISTINE SULPHATE-T-14 | 1 MG/ML IV VIAL (FLACON), 2 MG/ML IV VIAL (FLACON) |
CTD | Reference Data | ||
883 | VINORELBINE BITARTARAT-T-17 | 50MG/5ML IV VIAL (FLACON) | CTD | Reference Data | ||
884 | DOSETAXEL-T-23 | 20 MG/0.5 ML INJECTABLE SOLUTION (FLACON), 80MG/2 ML INJECTABLE SOLUTION (FLACON) |
CTD | Reference Data | ||
885 | BICALUTAMIDE-T-7 | 50 MG,150 MG FILM TABLET | CTD | Reference Data | ||
886 | TEMOZOLOMIDE-T-8 | 5 MG,20 MG,100 MG,140 MG,180 MG,250 MG CAPSULE | CTD | Reference Data | ||
887 | TAMOXIFENE CITRATE-T-15 | 10 MG,20 MG FILM TABLET | CTD | Reference Data | ||
888 | IMATINIB MESYLATE-T-16 | 100 MG,400 MG FILM TABLET | CTD | Reference Data | ||
889 | EXEMESTANE-T-18 | 25 mg draje turned out to be FILM TABLET | CTD | Reference Data | ||
890 | LETROZOL-T-19 | 2.5 MG FILM TABLET | CTD | Reference Data | ||
891 | PAMIDRONATE SODYUM-T-13 | 90 mg IV LYOPHYLISED POWDER VIAL (FLACON) | CTD | Reference Data | ||
892 | OXALIPLATIN-T-20 | 50 MG/10 ML LIOPHYLISED POWDER VIAL, 100 MG/20 ML LIOPHYLISED POWDER VIAL, 200 MG/40 ML LIOPHYLISED POWDER VIAL |
CTD | Reference Data | ||
893 | PEMETREXATE DISODIUM-T-21 | 500 MG/50 ML IV DRY POWDER INFUSION (FLACON), 100 MG/10 ML IV DRY POWDER INFUSION (FLACON) |
CTD | Reference Data | ||
894 | GEMCITABIN HCI-T-22 | 1 G IV LIOPHYLISED FLACON, 200 MG IV LIOPHYLISED FLACON |
CTD | Reference Data | ||
895 | PEG-FILGRASTIM-AR-72 | PEG-FILGRASTIM (6 MG / 0,6 ML) | CTD | Reference Data | ||
896 | INTERFRON ALFA2A-AR-73 | 3 MIU/ 0,5 ML,4,5 MIU/ 0,5 ML,6 MIU/ 0,5 ML,9 MIU/ 0,5 ML,8 MIU/ 0,5 ML | CTD | Reference Data | ||
897 | PEG-INTERFERON ALFA2A-AR-74 | 135 mcg / 0,5 ML,180 mcg / 0,5 ML | CTD | Reference Data | ||
898 | Dapoksetin – API | BENIDIPINE – API | CTD | Reference Data | ||
899 | BENIDIPINE – API | CTD | Reference Data | |||
900 | BUDESONIDE + FORMOTEROL FUMARATE D. | 80/4,5 mcg /120doz,160/4,5 mcg /120doz,320/9 mcg / 120 doz,160/9 mcg /120doz | CTD | Reference Data | ||
901 | DEXKETOPROFEN TROMETAMOL + THIOCOLCHICOSIDE | 25+8 mg/tablet, 25+4 mg/tablet, 1.25%+0.25% Gel, 50+4 mg/2 mL Injectable |
CTD | Reference Data | ||
902 | VALSARTAN + ESAMLODIPIN | 80+2.5 mg tablet,160+5 mg tablet,160+2,5 mg tablet,320+5 mg tablet,320+2,5 mg tablet | CTD | Reference Data | ||
903 | ESOMEPRAZOLE SODIUM | 40 mg/Flacon & POWDER FOR SOLUTION FOR INJECTİON/INFUSION | CTD | Reference Data | ||
904 | PARICALSITOL | Parkalsitol sıvı doldurulmuş sert kapsül 1MCG/ML, Parkalsitol sıvı doldurulmuş sert kapsül 2MCG/ML, Parkalsitol sıvı doldurulmuş sert kapsül 4MCG/ML |
CTD | Reference Data | ||
905 | AMOKLAVIN XR | 1000 mg / 62.5 mg tablet | CTD | Reference Data | ||
906 | METFORMIN HCL & REPAGLİNİDE | 500 mg Metformin HCl + 1 mg Repaglinide, 500 mg Metformin HCl + 2 mg Repaglinide & Tablet |
CTD | Reference Data | ||
907 | ERLOTINIB | 100 mg,150 mg,25 mg Film Kaplı tablet | CTD | Reference Data | ||
908 | ALVERINE + SIMETICONE | 60 mg + 300 mg Capsule | CTD | Reference Data | ||
909 | LENALIDOMIDE | 5 mg ,10 mg ,15 mg ,25 mg ,2,5 mg ,7,5 mg ,20 mg capsule | CTD | Reference Data | ||
910 | AZACITIDINE-BENDAMUSTINE | 60 mg + 300 mg Capsule | CTD | Reference Data | ||
911 | BENDAMUSTINE | 25 mg,100 mg lyophılızed | CTD | Reference Data | ||
912 | CANDESARTAN CILEXATIL & AMLODIPINE & HCTZ | 8 mg Candesartan Cilexetil-2,5 mg Amlodipin-12,5 mg HCTZ, 8 mg Candesartan Cilexetil-5 mg Amlodipin-12,5 mg HCTZ, 16 mg Candesartan Cilexetil-5 mg Amlodipin-12,5 mg HCTZ, 16 mg Candesartan Cilexetil-10 mg Amlodipin-12,5 mg HCTZ, 32 mg Candesartan Cilexetil-5 mg Amlodipin-12,5 mg HCTZ, 32 mg Candesartan Cilexetil-10 mg Amlodipin-12,5 mg HCTZ |
CTD | Reference Data | ||
913 | FINGOLIMOD – API | CTD | Reference Data | |||
914 | DAPTOMYCIN | 350 mg,500 mg,350 mg,500 mg,500 mg powder for injection | CTD | Reference Data | ||
915 | BUDESONIDE + FORMOTEROL | 80/4.5 Inhalation Aerosol, 120 inhalations, 80/4.5 Inhalation Aerosol, 60 inhalations, 160/4.5 Inhalation Aerosol, 120 inhalations, 160/4.5 Inhalation Aerosol, 60 inhalations |
CTD | Reference Data | ||
916 | Oxitropium Bromide API | CTD | Reference Data | |||
917 | FINGOLIMOD HCl | 0,5 mg capsule | CTD | Reference Data | ||
918 | BORTEZOMIB | 3,5 mg liyofilize | CTD | Reference Data | ||
919 | LENALIDOMIDE API | 3,5 mg liyofilize | CTD | Reference Data | ||
920 | POSACONAZOLE | 40 mg/ml Suspension,100 MG TABLET | CTD | Reference Data | ||
921 | CEFPROZIL | 500 mg FT,BMS ten transfer serozil, 250mg/5ml susp,BMS ten transfer |
CTD | Reference Data | ||
922 | PRAVASTATIN | Pravacol 20 mg,40 mg,10 mg tablet,BMS ten transfer | CTD | Reference Data | ||
923 | FLUPHENAZINE DECANOATE | Prolixin decaonate ampıl, BMS ten transfer | CTD | Reference Data | ||
924 | FOSINOPRIL SODIUM | Monopril 10 mg FT,BMS te transfer,Monopril 20 mg FT,BMS te transfer | CTD | Reference Data | ||
925 | FOSINOPRIL SODIUM+ HYDROCHLOROTHIAZIDE | Monopril plus 10 mg FT,BMS te transfer,Monopril plus 20 mg FT,BMS te transfer | CTD | Reference Data | ||
926 | HYDROXUREA | Hydrea 500 mg HGC,BMS ten transfer | CTD | Reference Data | ||
927 | MEGESTEROL ACETATE | Magace 160 mg FT, BMS ten transfer | CTD | Reference Data | ||
928 | NYSTATIN | Mikostatin OS,BMS ten transfer | CTD | Reference Data | ||
929 | TRIAMCINOLONE ACETONIDE | Kenakort Orabase ,BMS ten transfer,Kenakort A Pomad,BMS ten transfer,Kenakort IM Ampul,BMS ten transfer | CTD | Reference Data | ||
930 | Topiramate | Topax, 25 mg FT,Topax, 50 mg FT, Topax, 100 mg FT, Topax, 200 mg FT | CTD | Reference Data | ||
931 | Risedronate | Ostenat 5 mg FT,Ostenat 30 mg FT,Ostenat 35 mg FT | CTD | Reference Data | ||
932 | Ondansetron | Kemoset 4 mg FT,Kemoset 8 mg FT,Kemoset 4 mg/2 ml IM/IV Enjeksiyonluk Çözelti İçeren Ampul,Kemoset 8 mg/4 ml IM/IV Enjeksiyonluk Çözelti İçeren Ampul | CTD | Reference Data | ||
933 | Diklofenak Sodyum | Dilong SR 75 mg mikropellet kapsül,Duolast MR 75 mg modifiye salımınlı kapsül | CTD | Reference Data | ||
934 | Alfuzosin HCl | Alfuzosin 10 mg Prolonged Release (PR) Tablet | CTD | Reference Data | ||
935 | Anastrazol | anastrazol 1 mg Film Tablet | CTD | Reference Data | ||
936 | Trimetazidine DiHCl | Trimetazidine 35 mg/ MR Tablet | CTD | Reference Data | ||
937 | ORNIDAZOLE | Biteral 500 mg; Vaginal Tablet | CTD | Reference Data | ||
938 | MOCLOBEMİDE | Aurorix 150 mg/300 mg Film Tablet | CTD | Reference Data | ||
939 | AMİTRİPTYLİNE HCL | Laroxyl 10 mg/25 mg Draje | CTD | Reference Data | ||
940 | LEVODOPA + BENSERAZİDE HCL | Madopar 125 mg Capsule | CTD | Reference Data | ||
941 | TENOXİCAM | Tilcotil 20 mg IM/IV Lyo. Powder,Tilcotil 40 mg IM/IV Lyo. Powder | CTD | Reference Data | ||
942 | DICLOFENAC SODIUM | 40 MG IV LIOPHILIZED FLACON | CTD | Reference Data | ||
943 | SULFAMETHOXAZOLE + TRIMETHOPRIM | Bactrim 400+80 MG Film Tablet,Bactrim 800+160 MG Film Tablet | CTD | Reference Data | ||
944 | ORNIDAZOLE | Biteral 250 mg/500 mg Film Tablet | CTD | Reference Data | ||
945 | ACICLOVIR | Virosil 5%, Cream, 10 g/tube | CTD | Reference Data | ||
946 | GLYCERİN + TRİSODİUM CITRATE + SORBITOL | Sabalaks 350 mg/g + 90 mg/mL + 480 mg/g, Enema, 10 g/tube | CTD | Reference Data | ||
947 | DEXPANTHENOLE | Panthenol 5%, Pomade, 30 g/tube | CTD | Reference Data | ||
948 | DEXPANTHENOLE + CHLORHEXIDINE HCL | Panthenol Plus 5% + 0,5%; Cream, 30 g/tube | CTD | Reference Data | ||
949 | DEXPANTHENOLE | Panthenol 5%, Cream, 30 g/tube | CTD | Reference Data | ||
950 | OXICONAZOLE NITRATE | Oceral Roche 1%, Cream, 10 g/tube, Oceral Roche 1%, Solution, 20 mL/bottle |
CTD | Reference Data | ||
951 | DİFLUCORTOLONE VALERATE | Temetex 0,1%, Cream,Temetex 0,1%, Ointment,Temetex Fort 0,3%, Ointment | CTD | Reference Data | ||
952 | DİFLUCORTOLONE VALERATE + CHLORQUİNALDOL | Impetex 0,1% + 1% Cream | CTD | Reference Data | ||
953 | DİCLOFENAC SODİUM | 1 mg/ml eye drops single-dose | CTD | Reference Data | ||
954 | LATANOPROST/TİMOLOL | 50 μg/5 mg/ml eye drops | CTD | Reference Data | ||
955 | LATANOPROST | 50 μg/ml eye drops | CTD | Reference Data | ||
956 | TOBRAMYCİN | 0,3% Eye Drops | CTD | Reference Data | ||
957 | KETOTİFEN | 0.25 mg/ml Eye Drops | CTD | Reference Data | ||
958 | OFLOXACİN | 1,5 mg/0,5 ml eye drops single-dose | CTD | Reference Data | ||
959 | DORZOLOMİD-TİMOLOL | Dorzolamide/timolol 20 mg/5 mg/ml eye drop | CTD | Reference Data | ||
960 | LVP-13 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
961 | LVP-6 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
962 | LVP-12 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
963 | LVP-5 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
964 | LVP-7 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
965 | LVP-10 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
966 | LVP-11 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
967 | LVP-8 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
968 | LVP-3 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
969 | LVP-4 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
970 | LVP-9 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
971 | LVP-2 GLUCOSE | 5%, Large Vol. Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
972 | LVP-1 SODIUM CHLORIDE | 0.9%, Large Vol. Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
973 | LVP-14 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
974 | LVP-15 Electrolytes (NaCl, KCl, MgCl2, CaCl2 etc.) | Large Volume Parenteral with different volumes 100-1,000 mL. | CTD | Reference Data | ||
975 | CEFIXIME TRIHYDRATE | 200 mg/5 mL Suspension, 50 mL bottle/100 mL bottle | CTD | Reference Data | ||
976 | TADALAFIL | 20 mg Film Tablet, 2 tablets/box and 4 tablets/box | CTD | Reference Data | ||
977 | TENOFOVIR DISOPROXIL FUMARATE | Viread 245 mg Film Tablet | CTD | Reference Data | ||
978 | CLOBETASOLE PROPIONATE | 0.05%, Ointment, 50 g/tube,0.05%, Cream, 50 g/tube,0.05%, Lotion, 50 g/tube | CTD | Reference Data | ||
979 | DORZOLAMIDE HCL | 2% Multi-Dose Eye Drop, 5 mL | CTD | Reference Data | ||
980 | BRIMONIDINE TARTRATE | 0,2% Multi-Dose Eye Drop, 5 mL | CTD | Reference Data | ||
981 | TOBRAMYCIN BASE + DEXAMETHASONE | 0.3%+0.1%Multi-Dose Eye Drop, 5 mL/bottle | CTD | Reference Data | ||
982 | TIMOLOL MALEATE | 0.5% Unit-Dose Eye Drop | CTD | Reference Data | ||
983 | OLMESARTAN MEDOXOMIL | 5 mg FT,10 mg FT,20 mg FT,40 mg FT | CTD | Reference Data | ||
984 | LVP-16 Sodium Cloride | 3%, Large Vol. Parenteral with different volumes 100-250 mL. | CTD | Reference Data | ||
985 | LVP-22 Dextrose | 10%, Large Vol. Parenteral with different volumes 150-500 mL. | CTD | Reference Data | ||
986 | AMLODIPINE BESYLATE + VALSARTAN | 5+160 mg FT,10+160 mg FT,5+320 mg FT,10+320 mg FT | CTD | Reference Data | ||
987 | LVP-23 DEXTROSE MONOHYDRATE | 20%, Large Volume Parenteral, 500 mL. | CTD | Reference Data | ||
988 | LVP-19 MANNITOL | 20%, Large Volume Parenteral with different volumes (150 mL and 500 mL). | CTD | Reference Data | ||
989 | LVP-24 DEXTROSE MONOHYDRATE | 30% Large Volume Parenteral, 500 mL. | CTD | Reference Data | ||
990 | LVP-20 DEXTROSE MONOHYDRATE + SODIUM CHLORIDE | 5%+0.9%, Large Volume Parenteral with different volumes, (500 mL and 1000 mL). | CTD | Reference Data | ||
991 | LVP-21 DEXTROSE MONOHYDRATE + SODIUM LACTATE + SODIUM CHLORIDE + POTASSIUM CHLORIDE + CALCIUM CHLORID DIHYDRATE | 5%+0.31%+0.60%+0.03%+0.02%, Large Volume Parenteral with different volumes (500 mL and 1000 mL). | CTD | Reference Data | ||
992 | LVP-17 DEXTROSE MONOHYDRATE + SODIUM CHLORIDE | 3.33%+0.3%, Large Volume Parenteral with different volumes (250 mL and 500 mL). | CTD | Reference Data | ||
993 | LVP-25 SODİUM ACETATE TRIHYDRATE + SODIUM CHLORIDE + POTASSIUM CHLORIDE + SODIUM CITRATE DIHYDRATE + CALCIUM CHLORIDE DİHYDRATE + MAGNESİUM CHLORİDE HEXAHYDRATE | 0.64%+0.50%+0.075%+0.075%+0.035%+0.031%, Large Volume Parenteral with different volumes (500 mL and 1000 mL). | CTD | Reference Data | ||
994 | LVP-27 DEXTROSE MONOHYDRATE + SODIUM ACETATE TRIHYDRATE + POTASSIUM CHLORIDE + DIBASIC POTASSIUM PHOSPHATE + SODIUM CHLORIDE | 5%+0.28%+0.15%+0.13%+0.091%, Large Volume Parenteral with different volumes (500 mL and 1000 mL). | CTD | Reference Data | ||
995 | SILAZAPARIL | 1 mg/tablet,2.5 mg/tablet,5 mg/tablet | CTD | Reference Data | ||
996 | LVP-26 SODIUM ACETATE TRIHYDRATE + SODIUM CHLORIDE + POTASSIUM CHLORIDE + SODIUM GLUCONATE + MONOBASIC POTASSIUM PHOSPHATE + MAGNESIUM CHLORIDE HEXAHYDRATE + DIBASIC SODIUM PHOSPHATE HEPTAHYDRATE | 0.37%+0.53%+0.037%+0.5%+0.00082%+0.030%+0.012%, Large Volume Parenteral with different volumes (500 mL and 1000 mL). | CTD | Reference Data | ||
997 | OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDE | 40+25 mg/ film tablet,40+12.5 mg/ film tablet,20+25 mg/ film tablet,20+12.5 mg/ film tablet | CTD | Reference Data | ||
998 | CYCLOSPORINE A | 0.05% Eye Drop 0.4 mL /bottle (depores) | CTD | Reference Data | ||
999 | BRIMONIDINE TARTRATE | 0.15% Eye Drop 5 mL/bottle | CTD | Reference Data | ||
1000 | OLOPATADINE HYDROCHLORIDE | 0,1% Eye Drop 5 mL/bottle | CTD | Reference Data |